Biotech Acquisition Company Cl A (BIOT)
Biotech Acquisition Company Cl A (BIOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13 | 2 | 104 | 91 | 402 |
| TOTAL | $95 | $145 | $309 | $300 | $674 |
| Non-Current Assets | |||||
| Investments And Advances | 231,294 | 230,279 | 230,042 | 230,021 | 230,015 |
| TOTAL | $231,294 | $230,279 | $230,042 | $230,021 | $230,015 |
| Total Assets | $231,389 | $230,424 | $230,351 | $230,321 | $230,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,209 | 3,168 | 2,105 | 313 | 358 |
| Other current liabilities | 3 | 3 | 1 | 1 | 1 |
| TOTAL | $3,518 | $3,321 | $2,221 | $314 | $359 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 240,991 | 240,469 | 250,602 | 257,177 | 250,209 |
| TOTAL | $240,991 | $240,469 | $250,602 | $257,177 | $250,209 |
| Total Liabilities | $244,509 | $243,790 | $252,822 | $257,490 | $250,568 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,750 | 28,750 | 28,750 | 28,750 | 28,750 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -13,121 | -13,367 | -22,472 | -27,170 | -19,879 |
| TOTAL | $-13,120 | $-13,366 | $-22,471 | $-27,170 | $-19,878 |
| Total Liabilities And Equity | $231,389 | $230,424 | $230,351 | $230,321 | $230,690 |